期刊文献+

抗CD25人鼠嵌合抗体基因真核表达质粒的构建与瞬时表达 被引量:4

Construction and Transient Expression of Eukaryotic Expression Vector for Human-Mouse Chimeric Antibody Gene
原文传递
导出
摘要 目的构建抗CD25人鼠嵌合抗体基因真核表达质粒,并在293T细胞中进行瞬时表达。方法采用RT-PCR技术,设计针对信号肽的简并引物,钓取抗CD25杂交瘤细胞的重、轻链可变区基因,以质粒PAG4622为模板,钓取人抗体IgG1重、轻链恒定区基因,分别将重、轻链可变区基因与相应的恒定区基因进行拼接,将完整的重、轻链嵌合基因分别与真核表达载体pOptiVEC和pcDNA3.3连接,构建抗CD25人鼠嵌合抗体基因真核表达质粒,将其通过脂质体法共转染至293T细胞中进行表达。通过RT-PCR法检测嵌合抗体基因的转录水平,ELISA法检测嵌合抗体的表达量,流式细胞术(FCM)分析嵌合抗体的结合活性。结果抗CD25人鼠嵌合抗体基因真核表达质粒构建正确;RT-PCR显示嵌合抗体基因在293T细胞中成功转录;转染后48、72、96和120h,细胞培养上清中嵌合抗体的含量分别为7.47、11.72、8.02和18.28ng/ml;FCM检测其能特异性与IL-2Rα链结合。结论已成功构建了抗CD25人鼠嵌合抗体基因的真核表达质粒,并能在293T细胞中瞬时表达。 Objective To construct a eukaryotic expression vector for human-mouse chimeric antibody gene and express transiently in 293T cells. Methods The genes encoding variable regions of heavy and light chains of CD25 hybridoma cells were amplified by RT-PCR using the designed degenerate primers specific to signal peptide. The genes encoding constant regions of heavy and light chains of human IgG1 were amplified using plasmid PAG4622 as a template. The amplified genes encoding variable regions of heavy and light chains were spliced to the corresponding genes encoding constant regions. The obtained chimeric genes encoding heavy and light chains were inserted into eukaryotic expression vectors pOptiVEC and pcDNA3.3 respectively, and the constructed re- combinant plasmids were co-transfected to 293T cells for expression. The transcription level of chimeric antibody gene was determined by RT-PCR, the expression level of chimeric antibody by ELISA, and the binding activity of chimeric antibody by flow cytometry (FCM). Results The eukaryotic expression vector for human-mouse chimeric antibody gene was constructed correctly. RT-PCR proved that the chimeric antibody gene was successfully transcribed in 293T cells. The chimeric antibody contents in culture supernatant of 293T cells 48, 72, 96 and 120 h after transfection were 7. 47, 11. 72, 8. 02 and 18. 28 ng / ml respectively. FCM showed specific binding of the chimeric antibody to IL-2Rα chain. Conclusion The eukaryotic expression vector for human-mouse chimeric antibody gene was successfully constructed and expressed transiently in 293T cells.
出处 《中国生物制品学杂志》 CAS CSCD 2010年第2期113-117,共5页 Chinese Journal of Biologicals
关键词 CD25 嵌合抗体 瞬时表达 CD25 Chimeric antibody Transient expression
作者简介 通讯作者:杨晓明,E-mail:xmyang@wibp.com.cn
  • 相关文献

参考文献12

  • 1Waldmann TA. The interleukin-2 receptor. J Biol Chem, 1991, 266 (5): 2681-2684.
  • 2Kirkman RL, Shapiro ME, Carpenter CB, et al. A randomized prospective trial of anti-Tae monoclonal antibody in human renal transplantation. Transplantatian, 1991, 51 ( 1 ): 107-113.
  • 3Tsurushita N, Hinton PR, Kumar S. Design of humanized antibodies: from anti-tae to Zenapax. Methods, 2005, 36 ( 1 ): 69-83.
  • 4Paseual J, Marcen R, Ortuno J. Anti-interleukin-2 receptor anti-bodies: basiliximab and daelizumab. Nephrol Dial Transplant, 2001, 16 (9): 1756-1760.
  • 5张囡,李茜,郭长福,黎维勇,孙可芳,胡豫,张爱华.WuTac血药浓度双抗体夹心定量ELISA检测方法的建立及其临床应用[J].中国生物制品学杂志,2009,22(5):505-507. 被引量:2
  • 6Clark M. Antibody humanization: a case of the "emperors new clothes". Immunol Today, 2000, 21 (8): 397-402.
  • 7Coloma M J, Hastings A, Wims LA, et al. Novel vectors for the expression of antibody molecules using variable regions generated by polymerase chain reaction. J Immunol Methods, 1992, 152 (1): 89-104.
  • 8Norderhaug L, Olafsen T, Michaelsen TE, et al. Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells. J Immunol Methods, 1997, 204 (1): 77-87.
  • 9徐耀瑜,胡玲玲,陈永井,程钢,罗先富,孙杰,刘玉华,王艳茹,陈明心,邱玉华.CD80鼠-人嵌合抗体的CHO细胞表达及体外生物学功能的初步研究[J].中国免疫学杂志,2009,25(2):114-117. 被引量:10
  • 10Li J, Zhang C, Jostock T, et al. Analysis of IgG heavy chain to light chain ratio with mutant Encephalomyocarditis virus internal ribosome entry site. Protein Eng Des Sel, 2007, 20 (10): 491- 496.

二级参考文献17

  • 1瞿秋霞,陈永井,葛彦,王勤,陈成,杨明峰,张学光.抗人CD40人-鼠嵌合抗体的构建及其表达[J].细胞与分子免疫学杂志,2006,22(2):189-192. 被引量:10
  • 2瞿秋霞,陈成,王勤,葛彦,陈永井,邱玉华,张学光.抗人CD40人-鼠嵌合抗体在CHO细胞中的表达及其功能研究[J].细胞与分子免疫学杂志,2007,23(6):565-568. 被引量:2
  • 3Kozono Y, Abe R, Kozono H et al. Cross-linking CD21/CD35 or CD19 increases both BT-1 and B7-2 expression on murine splenic B cells[J] .J Immunol, 1998; 160(6) : 1565-1637.
  • 4Tan P,Mitchell D A, Buss T N et al. "Superhumanized" antibodies: reduction of immunogenic potential by complementarity-determining region grafting with human germline sequences: application to an anti-CD28 [ J]. J Immunol,2002; 169:1119-1125.
  • 5Hosono M, Endo K, Sakahara H et al. Human/mouse chimeric antibodies show low reactivity with human anti-murine antibodies (HAMA)[J] .Br J Cancer, 1992;65:197-200.
  • 6David G Schatz. V (D) J recombination[J]. Immunol Rev, 2004; 200: 5- 11.
  • 7William L Carroll, Elieen M, Shoshana L. Hybridoma fusion cell lines contain an aberrant kappa transcript[J]. Mole Immunol, 1988; 10(25) :991- 995.
  • 8Deyev S M, Polanovsky O L. Expression of chimeric immunoglobulin genes in mammalian cells [ J ]. Methods Mol Biol, 1995 ; 51 : 251-263.
  • 9Hudson P J, Souriau C. Engineered antibodies [ J ]. Nat Med, 2003 ; 9 (1) : 129-134.
  • 10Soulillou JP, Cantarovich D, Le Mauff B, et al. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.!) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts. N. Engl J Med, 1990, 322(17): 1175-1182.

共引文献10

同被引文献40

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部